Figure 1.
Forest plot of case series assessing the risk of HBV reactivation in lymphoma patients treated with rituximab-based therapy compared with nonrituximab controls.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.